Hematoma growth in oral anticoagulant related intracerebral hemorrhage

Stroke

Volumn 39, Issue 11, 2008, Pages 2993-2996

  Cucchiara, Brett ^a   Messe, Steven ^a   Sansing, Lauren ^a   Kasner, Scott ^a   Lyden, Patrick ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anticoagulation; Intracerebral hemorrhage; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; DISUFENTON SODIUM; PLACEBO;

AGE DISTRIBUTION; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROIMAGING; NEUROPROTECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; CHEMICALLY INDUCED DISORDER; HEMATOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; FEMALE; HEMATOMA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLACEBOS; PROGNOSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 55749099163     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.520668     Document Type: Article

References (11)

1. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intra-cerebral hemorrhage. Arch Intern Med. 2004;164:880-884.
2. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Begtrup K, Steiner T, for the Recombinant Activated Factor VIIIHTI. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175-1181.
3. Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: Current practices and unresolved questions. Stroke. 2006;37:256-262.
4. Lyden PD, Shuaib A, Lees KR, Davalos A, Davis SM, Diener HC, Grotta JC, Ashwood TJ, Hardemark HG, Svensson HH, Rodichok L, Wasiewski WW, Ahlberg G. Safety and tolerability of nxy-059 for acute intracerebral hemorrhage: The chant trial. Stroke. 2007;38:2262-2269.
5. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059-1064.
6. Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T, Skolnick BE, Davis SM. Determinants of intracerebral hemorrhage growth: An exploratory analysis. Stroke. 2007;38:1072-1075.
7. Sjoblom L, Hardemark H-G, Lindgren A, Norrving B, Fahlen M, Samuelsson M, Stigendal L, Stockelberg D, Taghavi A, Wallrup L, Wallvik J. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: A Swedish multicenter study. Stroke. 2001;32:2567-2574.
8. Huttner HB, Steiner T, Hartmann M, Kohrmann M, Juettler E, Mueller S, Wikner J, Meyding-Lamade U, Schramm P, Schwab S, Schellinger PD. Comparison of abc/2 estimation technique to computer-assisted plani-metric analysis in warfarin-related intracerebral parenchymal hemorrhage. Stroke. 2006;37:404-408.
9. Huttner HB, Schellinger PD, Hartmann M, Kohrmann M, Juettler E, Wikner J, Mueller S, Meyding-Lamade U, Strobl R, Mansmann U, Schwab S, Steiner T. Hematoma growth and outcome in treated neuro-critical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: Comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37:1465-1470.
10. Yasaka M, Minematsu K, Naritomi H, Sakata T, Yamaguchi T. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost. 2003;89:278-283.
11. Lee SB, Manno EM, Layton KF, Wijdicks EF. Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology. 2006;67:1272-1274.